Trinoib can be used to for patients with Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS), which have continued to be topical and current issues globally, especially in Africa, since their debut over a quarter of a century ago. In Africa, HIV and AIDS have become very important issues surfacing regularly in significant discussions on education, the economy, security and the general health of the population. It seems no issue of importance could be discussed comprehensively without paying due attention
to and including HIV and AIDS. Trino IB, a proven immune-boosting preparation in animal studies (Oloke, 2008), is administered to HIV seropositive persons to observe the effects it might have on their immunity. Of the thirty volunteers who have been recruited so far for the study, sufficient data on ten of them are currently available for analysis, each having had at least two CD4 counts at three months intervals since they began to take Trino IB.
Click here to read more